CD
Insider
Carl Dambkowski
DirectorCarl Dambkowski (Director) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
14
0 buys · 14 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$18.5M
shares × price, as filed
Last traded
Aug 5
Filed Aug 7
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $20.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
14 filings
Sector per market data · by filing · past 12 months
Most traded names
APGERecent filings
APGESALE
Apogee Therapeutics, Inc.
View filing →
$376K5,300 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $161K
2,481 sh × $64.88
Exec Feb 4
Filed Feb 4 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.4M
17,774 sh across 2 lots
Exec Jan 7
Filed Jan 9 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $818K
10,900 sh × $75.00
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $556K
10,107 sh across 3 lots
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $203K
5,110 sh × $39.80
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $103K
2,725 sh × $37.78
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $420K
9,344 sh across 2 lots
Exec Jul 2 2025
Filed Jul 3 2025 · 5:30 PM ET More filings →